参考文献/References:
[1] 王军, 肖林林, 程云杰. 局部进展期食管癌新辅助治
疗研究进展 [J]. 中华放射肿瘤学杂志,2018,27(8):709-
720.
WANG Jun, XIAO Linlin, CHENG Yunjie. Research
progress in neoadjuvant treatment of locally advanced
esophageal cancer[J].Chinese Journal of Radiation of
Oncology, 2018,27(8):709-720.
[2] 鲍艳红，黄常新. 放射性肺炎的发病机制及其防治
研究进展[J]. 实用医学杂志，2015，31(21):3621-
3623.
BAO Yanhong , HUANG Changxin. Research progress
in the pathogenesis and prevention of radiation
pneumonia[J].The Journal of Practical Medicine,
2015，31(21):3621-3623.
[3] 何佳欣，朱小辉，鞠永健.KL-6 与放射性肺炎的相
关研究进展[J]. 癌症进展，2014,12（3）：242-245.
HE Jiaxin, ZHU Xiaohui, JU Yongjian. Research progress
of KL-6 and radiation pneumonia [J]. Oncology
Progress, 2014,12（3）: 242-245.
[4] 李波，赵永利，李开艳，等．放疗致肺癌患者发生
放射性肺炎的影响因素研究[J]．中国全科医学，
2015, 18（14）: 1659-1662.
LI Bo, ZHAO Yongli, LI Kaiyan, et al. Influencing
factors for radiation pneumonitis induced by radiation
therapy for lung cancer [J]. Chinese General Practice,
2015，18（14）：1659-1662.
[5] SATO H, CALLISTER M E, MUMBY S, et al． KL-6
levels are elevated in plasma form patients with acute
respiratory distress syndrome [J]． Eur Respir J，
2004,23 (1) : 142-145．
[6] MIYAZAKI K, KURISHIMA K, KAGOHASHI K, et
al． Serum KL-6 levels in lung cancer patients with or
without interstitial lung disease [J]． J Clin Lab Anal，
2010，24(5) ∶ 295-299．
[7] SAKAMOTO K, TANIGUCHI H, KONDOH Y, et al.
Serum KL-6 in fibrotic NSIP: Correlations with physiologic
and radiologic parameter[J]. Respir Med，2010,
104 (1): 127-133．
[8] ICHIYASU H, ICHIKADO K, YAMASHITA A, et al
．Pneumocyte biomarkers KL-6 and surfactant protein
D reflect the distinct findings of high-resolution computed
tomography in nonspecific interstitial pneumonia
[J]．Respiration, 2012, 83 (3): 190-197.
[9] 王冉冉，朱剑，张江林. KL-6 在间质性肺疾病诊治
中的研究进展[J]. 解放军医学杂志，2017,42（4）：
354-357.
WANG Ranran, ZHU Jian, ZHANG Jianglin. Advances
in the research on application of KL-6 in the diagnosis
and treatment of interstitial lung disease[J].Medical
Journal of Chinese people’s Liberation Army, 2017,42
（4）：354-357.
[10] 温翠侠, 孙凌飞, 吴承俊, 等. 食管癌单纯放疗及同
期放化疗患者急性不良反应影响因素[J]. 北华大学
学报( 自然科学版),2019, 20(1):77-81.
WENG Cuixia, SUN Lingfei, WU Chengjun. Impact
of radiotherapy and cxoncurrent chemoradiotherapy
on acute adverse reactions in patients with esophageal
cancer[J]. Journal of Beihua University(Natural Science),
2019, 20(1):77-81.
[11] 张鹏，王永才，张喜报，等 . 血清降钙素原、炎症
细胞因子及超敏 C- 反应蛋白联合检测放射性肺炎
合并肺部感染的诊断价值 [J]. 中华医院感染学杂
志,2017,27(23):5322-5324, 5347.
ZHANG Peng, WANG Yongcai, ZHANG Xibao, et al.
Diagnostic value of serum calcitonin, inflammatory
cytokines and high sensitivity C-reactive protein in the
diagnosis of radiation pneumonia complicated with pulmonary
infections[J]. Chinese Journal of Nosocomiology,
2017,27(23):5322-5324, 5347.
[12] GOTO K, KODAMA T, SEKINE I, et al. Serum levels
of KL-6 are useful biomarkers for severe radiation
pneumonitis[J].Lung Cancer, 2001, 34(1)：141-148.
[13] MIYAZAKI Y, TSUTSUI T, INASE N．Treatment and
Monitoring of hypersensitivity pneumonitis[J]．Expert
Rev Clin Immunol，2016，12(9)：953-962．
[14] WASEDA K, OCHO K, HASEGAWA K, et a1．Increased
serum KL-6 levels induced by pulmonary mycobactefium
avium complex infection in a patient with
RA-associated lung disease[J]．Acta Med Okayama，
2016, 70(3)：217-221．
[15] SUWABE A．Lung injury and serum markers[J]．
Rinsho Byori, 2002，50(11)：1061-1066．
[16] 蒋娟，胡成平. 放射性肺炎发病机制及治疗进展[J].
国际呼吸杂志，2015，35（18）：1427-1430.
JIANG Juan, HU Chengping. Advances in pathogenesis
and treatment of radiation pneumonitis[J].International
Journal of Respiration, 2015, 35（18）: 1427-1430.
相似文献/References:
[1]张 振,李 力,徐翠香,等.血清TAM和Cyfra21-1检测在食管癌诊断和化疗疗效判定中的价值[J].现代检验医学杂志,2015,30(04):150.[doi:10.3969/j.issn.1671-7414.2015.04.046]
ZHANG Zhen,LI Li,X(¨overU)Cui-xiang,et al.Value of Detecting Serum TAM and Cyfra21-1 Levels in the Diagnosis
and Chemotherapeutic Efficacy of Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2015,30(03):150.[doi:10.3969/j.issn.1671-7414.2015.04.046]
[2]朱卫华,刘继斌.血浆相关基因甲基化在食管癌复发中的临床价值[J].现代检验医学杂志,2016,31(04):93.[doi:10.3969/j.issn.16717-414.2016.04.025]
ZHU Wei-hua,LIU Ji-bin.Clinical Significance of Promoter Hypermethylation of Esophageal
Squamous Cell Carcinoma(ESCC)in Plasma[J].Journal of Modern Laboratory Medicine,2016,31(03):93.[doi:10.3969/j.issn.16717-414.2016.04.025]
[3]肖小平,张 熊sub>a,秦光明b.食管癌和良性食管疾病患者血浆miRNA-21和miRNA-143检测的临床应用研究[J].现代检验医学杂志,2017,32(04):72.[doi:10.3969/j.issn.1671-7414.2017.04.020]
XIAO Xiao-ping,ZHANG Xionga,QIN Guang-mingb.Clinical Research of Detecting Plasma MiRNA-21 and MiRNA-143
for Identifying Early Esophageal Cancer and Benign Esophageal Diseases[J].Journal of Modern Laboratory Medicine,2017,32(03):72.[doi:10.3969/j.issn.1671-7414.2017.04.020]
[4]邱 巍,胡 威,赵建江,等.江苏宿迁地区汉族人群DNMT3B基因启动子区-149C>T和-579G>T多态性与食管癌易感性的分析[J].现代检验医学杂志,2018,33(02):28.[doi:10.3969/j.issn.1671-7414.2018.02.001]
QIU Wei,HU Wei,ZHAO Jian-jiang,et al.Study on the Promoter Region -149C>T
and -579G>T Polymorphism of DNMT3B with Genetic Susceptibility
to Esophageal Cancer of Han Population in Jiangsu Suqian[J].Journal of Modern Laboratory Medicine,2018,33(03):28.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[5]梁晓虎,郭俊霞,雷尚昆.食管癌组织中lnc RNA DNAJC3-AS1的表达及其与临床病理特征的相关性研究[J].现代检验医学杂志,2021,36(02):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
LIANG Xiao-hu,GUO Jun-xia,LEI Shangkun.Expression of Lnc RNA DNAJC3-AS1 in Esophageal Carcinoma Tissues and Its Correlation with Clinicopathological Features[J].Journal of Modern Laboratory Medicine,2021,36(03):75.[doi:doi:10.3969/j.issn.1671-7414.2021.02.018]
[6]朱 娇a,孙国才b,刘素荣a,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
ZHU Jiaoa,SUN Guo-caib,LIU Su-ronga,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(03):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[7]贾东辉,杜 宇,黄 飞,等.食管癌患者行根治性切除术后血清miR-216a和Bcl-2mRNA表达水平及与预后的相关性研究[J].现代检验医学杂志,2022,37(02):93.[doi:10.3969/j.issn.1671-7414.2022.02.020]
JIA Dong-hui,DU Yu,HUANG Fei,et al.Expression Levels of Serum miR-216a and Bcl-2 mRNA and Their Correlation with Prognosis in Patients with Esophageal Cancer after Radical Resection[J].Journal of Modern Laboratory Medicine,2022,37(03):93.[doi:10.3969/j.issn.1671-7414.2022.02.020]
[8]刘 伟a,周 杨a,边 超a,等.miR-495 对食管癌细胞株Eca109 在不同放射剂量和顺铂浓度作用的影响及机制研究[J].现代检验医学杂志,2022,37(04):13.[doi:10.3969/j.issn.1671-7414.2022.04.003]
LIU Weia,ZHOU Yanga,BIAN Chaoa,et al.Effect of miR-495 on Esophageal Cancer Cell Line Eca109 at Different Radiation Doses and Cisplatin Concentrations and Its Mechanism[J].Journal of Modern Laboratory Medicine,2022,37(03):13.[doi:10.3969/j.issn.1671-7414.2022.04.003]
[9]周立远,叶玉祥,林 琳,等.LncRNA CCAT1 调节miR-155 表达增强CD8+T 细胞对食管癌抗肿瘤活性的机制研究[J].现代检验医学杂志,2023,38(03):79.[doi:10.3969/j.issn.1671-7414.2023.03.014]
ZHOU Li-yuan,YE Yu-xiang,LIN Lin,et al.Mechanism of LncRNA CCAT1 Regulating miR-155 Expression and Enhancing Anti-tumor Activity of CD8+T Cells Against Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2023,38(03):79.[doi:10.3969/j.issn.1671-7414.2023.03.014]